Very excited to share that we are working with the @UMBaltimore to advance clinical investigations of Vortex's technology alongside UMB's pioneering Tetherchip research. This research team will gain unprecedented insights into #cancer biology tinyurl.com/y8jv46t9
Welcome to industry veteran Nigel Brooksby who has joined our Board as Non-Executive Chairman. Nigel’s experience speaks for itself, notably he was Chairman & CEO of Sanofi UK. Read more about our growth plans here: tinyurl.com/y49rhbns#oncology#liquidbiopsy#growth
Vortex recently hosted a webinar in collaboration with @PistoiaAlliance, exploring the role of liquid biopsies in advancing precision medicine, with a specific focus on the significance of Rare Cells in a landscape centred around ctDNA.
Watch the webinar: vimeo.com/886906834?share=co…
We're so pleased that @VortexBioSci is expanding liquid biopsy research at The London Cancer Hub’s Innovation Gateway.
The London Cancer Hub is a partnership led by the ICR and the @SuttonCouncil🤝
Learn more below👇
icr.ac.uk/news-archive/new-m…
Vortex is delighted to announce the completion of a ÂŁ3.2 million investment round, led by @EMVCapital, to support its next phase of growth.
Learn more ➡️lnkd.in/d4SX4jq5
NetScientific is delighted to announce the completion of a ÂŁ3.2 million investment round in its portfolio company @VortexBioSci, led by its corporate finance and VC arm @EMVCapital.
Learn more➡️polaris.brighterir.com/publi…
CEO of Vortex Biosciences, Paul Jones, featured in the @GOLD_pharma article exploring the UK’s life science initiatives designed to develop a stronger foothold in the global pharma industry and create world-class treatments for patients.
emg-gold.com/post/pharma-in-…
Vortex is pleased to announce and extend a warm welcome to recent key hires.
▶️Dennis Hutchison - Chief Commercial Officer and US Lead
▶️Jacqueline Hall - VP, Offering Development
▶️John Matthews - VP, Clinical Operations
Vortex is delighted to announce that it has opened a laboratory at The London Cancer Hub’s Innovation Gateway in support of its next phase of growth. The new laboratory is in addition to Vortex’s existing facility in San Francisco, California.
@ICR_London@SuttonCouncil
Paul Jones, CEO of Vortex Biosciences, will be attending the @PistoiaAlliance Annual Spring Conference in London next Tuesday, April 18.
Learn more about the event: pistoiaalliance.org/eventdet…
“An entrepreneurial culture arises from challenging dogma and the status quo. I lead by example in challenging other approaches and question "why things are done the way they are"...”
Dino Di Carlo (@dinodicarlo)— Prof @UCLA
Shoutout: @VortexBioSci, @Cytovale, @UCLATDG, & more
We are pleased to announce the appointment of Paul Jones as CEO of @VortexBioSci. Paul will lead the company's growth strategy around the core technology of the VTX-1 platform for the collecting of viable CTCs, in the growing oncology liquid biopsy market,
NetScientific acquires a strategic 30% stake in Vortex Biotech Holdings, owner of former investee company @VortexBioSci. The acquisition is in line with the Company's strategy of deepening stakes in selected portfolio companies with high return potential. lnkd.in/eJyyzYpj